Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese drugmaker. Kim, 54, has been running ...

Julie Kim was promoted to president of the U.S. business unit of Takeda after three years heading up the company's plasma-derived therapies division. She has been named a 2022 honoree of the BBJ's ...

Mimi Flower, left, and Julie Kay kiss while Flower fills out an application for a marriage license while waiting in a long line outside of the marriage division of the Salt Lake County Clerk's ...

Julie Kim is due to be promoted to chief executive of Takeda Pharmaceutical Co. next year. First, though, the head of the Japanese drugmaker’s US operations had some business advice to share ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management, buzzwords like purpose, ... a FTSE 100 company in the U.K., said the skills she gained in business school have served as key ...

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese companies ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Takeda Pharmaceutical 4502-0.23 % decrease; red down pointing triangle named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, ...